Integrating network reconstruction with mechanistic modeling to predict cancer therapies
Files in This Item:
|Integrating network reconstruction with mechanistic modelling to predict potential cancer therapy.pdf||1.77 MB||Adobe PDF||Download|
|Title:||Integrating network reconstruction with mechanistic modeling to predict cancer therapies||Authors:||Halasz, Melinda
Kholodenko, Boris N.
|Permanent link:||http://hdl.handle.net/10197/9755||Date:||22-Nov-2016||Online since:||2019-04-01T10:14:05Z||Abstract:||Signal transduction networks (STNs) are often rewired in cancerous cells. Effective cancer treatment requires identifying and repairing these harmful alterations. We developed a computational framework which can identify these aberrations and predict potential targets for intervention. It reconstructs network models of STNs from noisy and incomplete perturbation response data, and then uses the reconstructed networks to develop mechanistic models of STNs for predicting potential treatments. As a proof of principle, we analysed a perturbation dataset targeting Epidermal Growth Factor Receptor (EGFR) and Insulin like 2 Growth Factor 1 Receptor (IGF1R) pathways in a panel of colorectal cancer (CRC) cells, revealing cell line specific STN rewiring. Specifically, we found that the feedback inhibition of IRS1 by p70S6K is associated with resistance to EGF receptor (EGFR) inhibition, and disrupting this feedback may restore sensitivity to EGFR inhibitors in CRC cells. These findings were experimentally validated in vitro and in zebrafish (Danio rerio) xenografts.||Funding Details:||European Commission - Seventh Framework Programme (FP7)
Science Foundation Ireland
|Type of material:||Journal Article||Publisher:||American Association for the Advancement of Science||Journal:||Science Signaling||Volume:||9||Issue:||455||Copyright (published version):||2016 the American Association for the Advancement of Science||Keywords:||Network inference; Cancer therapies; Mechanistic modeling; Signal transduction pathways; Modular response analysis; Bayesian inference; Drug resistance; Signal transduction networks||DOI:||10.1126/scisignal.aae0535||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Conway Institute Research Collection|
SBI Research Collection
Medicine Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.